20 Aug 2021
Plasma Fractionation Market extrapolated to grow from $27.45 Billion in 2020 to reach $42.66 Billion by 2027 at a Compound Annual Growth Rate (CAGR) of 6.5%. The base year for the study is 2020 and the forecast period is considered to be 2021 to 2027.
Plasma Fractionation Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Rising prevalence of respiratory diseases like alpha-1 antitrypsin deficiency (ATTD) along with growing geriatric population and increasing use of immunoglobulins in various therapeutic applications are some of the key factors accelerating the plasma fractionation market globally.
Request Sample of the Report: https://brandessenceresearch.com/requestSample/PostId/1298
Scope of Plasma Fractionation Market-
Blood fractionation is the process of fractionating whole blood, or separating it into its component parts. This is naturally done by centrifuging the blood. Fractionation is a process which is carried out to separate certain quantity of mixture. Plasma-derived immunoglobulins are giving a new narrative to healthcare across a wide range of autoimmune and inflammatory diseases. Plasma contains a large variety of proteins including albumin, immunoglobulins, and clotting proteins such as fibrinogen. It is also employed to stop excessive blood loss during surgical procedures. Similarly, immunoglobulins are employed in the treatment of primary and secondary immune deficiencies. Plasma imitative immunoglobulins are being progressively used in multiple clinical indications such as autoimmune and inflammatory diseases.
Plasma Fractionation market report is segmented on the basis of product type, application, end user and by regional & country level. Based upon product type, plasma fractionation market is classified into immunoglobulin, coagulation factor, concentrates, albumin, protease inhibitors and others. Based upon application, plasma fractionation market is classified into neurology, immunology, homology, critical care, pulmonology, hemoto-oncology, rheumatology and others. Based upon end user, plasma fractionation market is classified into hospitals & clinics, clinical research laboratories and academic institutes.
Key Players for Global Plasma Fractionation Market Report:
Global plasma fractionation market reports cover prominent players CSL, Grifols, Shire, Octapharma, Kedrion, LFB, Biotest, Sanquin, China Biologic Products, Bio Prodcuts Laboratory (BPO), Japan Blood Products Organization, Green Cross Corporation, and others.
Global Plasma Fractionation Market Segmentation:
Global plasma fractionation market is segmented on the basis of product type, application, end-user, and region & country level. On the basis of product type, plasma fractionation market is classified as immunoglobulin, coagulation factor, concentrates, albumin, protease inhibitors and others. On the basis of application, the market is classified as neurology, immunology, homology, critical care, pulmonology, hemoto-oncology, rheumatology and others. On the basis of end-user, the plasma fractionation market is classified as hospitals & clinics, clinical research laboratories and academic institutes.
By Product Type:
Hospitals & Clinics
Clinical Research Laboratories
The regions covered in global plasma fractionation market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of plasma fractionation market sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
North America is Expected to Dominate Global Plasma Fractionation Market
North America is expected to dominate the global plasma fractionation market with the potential rate due to increasing prevalence of respiratory diseases, and the increasing use of immunoglobulin in various therapeutic areas in this region. According to the National Center for Health Statistics, presently in excess of 25 million individuals in the United States have asthma and about 14.8 million adults have been determined to have COPD. COPD is the fourth driving reason for death in the United States.
The Asia Pacific is expected to emerge as the fastest-growing region for plasma fractionation market over the forecast period due to increasing number of plasma collection centers, high investment in drug discovery and developing healthcare research infrastructure in this region. For instance, according to the WHO, an increase of 7.8 million blood donations from charitable donors has been reported from 2013 to 2018. Only 55 of 171 reporting nations produce plasma-derived medicinal products (PDMP) during the fractionation of plasma together in the country. In April 2020, the Indian Council for Medical Research (ICMR) APPROVED Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST, India) to foster a convention for improving plasma treatment trials to treat seriously sick COVID-19 patients.
Key Benefits for Global Plasma Fractionation Market Report:
Global Plasma Fractionation Market report covers in depth historical andforecast analysis.
Global Plasma Fractionation Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Plasma Fractionation Market report helps to identify opportunities in market place.
Global Plasma Fractionation Market report covers extensive analysis of emerging trends and competitive landscape.
Request Methodology of the Report: https://brandessenceresearch.com/requestMethodology/PostId/1298
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org